Experience
AbbVie Inc., et al. v. Aurobindo Pharma U.S.A., Inc. et al.
AbbVie Inc.
Aurobindo Pharmaceutical U.S.A, Inc. et al.
Finnegan is representing AbbVie, Allergan, and Merck in ongoing ANDA litigation involving Ubrelvy®, indicated for the acute treatment of migraine with or without aura in adults.
AbbVie Inc. v. Aurobindo Pharmaceutical U.S.A, Inc. et al., 3:24-cv-04603, D.N.J., Judge Quraishi, Day
AbbVie Inc. v. Aurobindo Pharmaceutical U.S.A, Inc. et al., 3:24-cv-04662, D.N.J., Judge Quraishi, Day
AbbVie Inc. v. Aurobindo Pharmaceutical U.S.A, Inc. et al., 3:24-cv-04852, D.N.J., Judge Quraishi, Day
Related Professionals
- Emma N. Ng
- Associate
- Washington, DC
- +1 202 408 4149
- Shannon M. Patrick
- Associate
- Atlanta, GA
- +1 404 653 6558